Lv1
68 积分 2023-08-13 加入
Tu1845: EFFECTIVENESS AND SAFETY OF ADVANCED COMBINATION TREATMENT (ACT) IN PATIENTS WITH REFRACTORY INFLAMMATORY BOWEL DISEASE OR CONCOMITANT IMMUNE-MEDIATED DISEASE OR EXTRA-INTESTINAL MANIFESTATIONS: A MULTI-CENTER CANADIAN STUDY
5天前
已完结
Letter: combination of biologics in inflammatory bowel diseases
23天前
已完结
Challenges in the Medical and Surgical Management of Chronic Inflammatory Bowel Disease
1个月前
已完结
Inflammatory Bowel Disease
1个月前
已完结
The Therapeutic Potential of MAPK/ERK Inhibitors in the Treatment of Colorectal Cancer
1个月前
已完结
Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn’s disease
2个月前
已完结
Efficacy and Safety of Vedolizumab and Tofacitinib (VETO) Combination Therapy in Refractory Ulcerative Colitis Unresponsive to Anti‐TNF and a Second‐Line Advanced Therapy: A Prospective Cohort Nested Within a Randomised Trial
2个月前
已完结
Safety and tolerability of concurrent natalizumab treatment for patients with Crohnʼs disease not in remission while receiving infliximab
2个月前
已完结
皖公网安备34019202002308
